Abstract 2996: Overexpression of potential oncogenic microRNAs defines a new molecular subclass of hepatocellular carcinoma
Sara Toffanin(UiT The Arctic University of Norway), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Jun Lü(Yale Cancer Center), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Radoslav Savić(Tisch Hospital), Laia Cabellos(Icahn School of Medicine at Mount Sinai), Beatriz Mínguez, Augusto Villanueva(NYU Langone Health), Derek Y. Chiang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Jordi Bruix(Hospital Clínic de Barcelona), Anja Lachenmayer(Düsseldorf University Hospital), Samuel Waxman(Icahn School of Medicine at Mount Sinai), Todd R. Golub(Broad Institute), Sasan Roayaie(White Plains Hospital), Yujin Hoshida(Broad Institute)
Cited by 2
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k